Angina Pectoris Drugs Market   Global Outlook and Forecast 2029

Angina Pectoris Drugs Market  was valued at US$ 11.78 Bn in 2022, and it is expected to reach US$ 16.02 Bn by 2029, exhibiting a CAGR of 4.49 % during the forecast period 2023-2029

Angina Pectoris Drugs Market Overview:

Extensive primary and secondary research Angina Pectoris Drugs Market has been undertaken by a dedicated research team to conduct a comprehensive study of the worldwide industry’s market. The secondary research was employed to augment existing data, segment the market, evaluate the overall market size, forecast growth rates, and delve deeper into market analysis.

To remain ‘ahead’ of your competitors, request for a sample 

Angina Pectoris Drugs Market Scope:

Maximize, our team, aggregates market information and data from various sources to offer a more realistic regional perspective. The country-level analysis within the study relies on an examination of numerous regional stakeholders, regional tax regulations, consumer behavior patterns, and macroeconomic statistics.

Angina Pectoris Drugs Market Drivers:

Angina pectoris is a heart disorder marked by a narrowing of the coronary arteries, resulting in a reduction in blood flow to the heart. Squeezing, heaviness, tightness, or pain in the chest are some of the symptoms. Chest pain, uneasiness, dizziness, weariness, nausea, shortness of breath, and sweating were all symptoms of angina pectoris. Antianginal medicines are medications that are used to treat angina pectoris. Angina pectoris attacks can be prevented, aborted, or terminated with the use of these medications. Antianginal medicines reduce oxygen demand, improve oxygen transport to the heart, block calcium channels, and prevent platelet aggregation.

Because of the increased focus on treating medical problems that affect the older population, the global market for angina pectoris medications has seen an increase in demand. The development of a unified sector for healthcare diagnostics and treatment has aided market expansion significantly. Reduced blood supply to the heart causes angina pectoris, which is a type of chest pain. Angina pectoris occurs more frequently in the elderly population. For the treatment of angina pectoris, a variety of medications have been produced, which is a crucial consideration in terms of market growth. These medications aid in the regulation of blood flow to the heart, which compensates for a lack of blood supply.

Angina Pectoris Drugs Market Segmentation:

by Therapeutic

Class Nitrates
Beta Blockers
Calcium Channel Blockers
Angiotensin-converting Enzyme Inhibitors (ACE Inhibitors)

by Type

Stable Angina
Unstable Angina
Prinzmetal’s Angina

by End User

Special Clinic

Request A Free Sample 

Angina Pectoris Drugs Market Key Players: The prominent players include:

1. Sanofi
2. Pfizer
3. Otsuka Pharmaceutical Co., Ltd.
4. Novartis AG
5. Merck & Co., Inc.
6. Gilead Sciences, Inc.
7. Amgen Inc.
8. Eli Lilly and Company
9. GlaxoSmithKline
10. Axus Cardium Pharmaceuticals
11. LegoChem Biosciences
12. Lee’s Pharmaceutical Holdings
13. Milestone Pharmaceuticals
14. Juventas Therapeutics
15. ViroMed
16. Kuhnil Pharmaceutical
17. Johnson & Johnson
18. Bristol-Myers Squibb Company
19. Abbott
20. Bayer AG

Regional Analysis:

The country-level assessment of the Angina Pectoris Drugs Market focuses on categories identified as potential areas for high growth, countries holding significant market shares, and those demonstrating high developmental prospects. Regional breakdowns in the Angina Pectoris Drugs Market report encompass North America (USA, Canada), South America, Asia Pacific (China, Japan, India, Korea), Europe (Germany, UK, France, Italy), and Other countries.

To Gain A Better Understanding Of Angina Pectoris Drugs Market 

COVID-19 Impact Analysis on Angina Pectoris Drugs Market: The report also incorporates an analysis of the impact of COVID-19 on the global Angina Pectoris Drugs market.

Key Questions Addressed in the Angina Pectoris Drugs Market Report:

  1. Which product segment dominated the Angina Pectoris Drugs market share in 2020?
  2. How is the anticipated competitive landscape of the Angina Pectoris Drugs market forecasted for the period 2021-2027?
  3. What are the primary factors contributing to the growth of the Angina Pectoris Drugs market?
  4. Which region accounted for the largest share in the Angina Pectoris Drugs market in 2020?
  5. What is the projected Compound Annual Growth Rate (CAGR) of the global Angina Pectoris Drugs market during the forecast period (2021-2027)?

More Related Reports Of Maximize Market Research:  

Global Spatial Genomics & Transcriptomics Market 

Prepaid Card Market 

About Maximize Market Research: 

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

+91 96071 95908, +91 9607365656


Leave a Reply

Your email address will not be published. Required fields are marked *